Site Sponsors
  • Oxford Instruments Nanoanalysis - X-Max Large Area Analytical EDS SDD
  • Park Systems - Manufacturer of a complete range of AFM solutions
  • Strem Chemicals - Nanomaterials for R&D

Nanotechnology, NanoMedicine and Nanotoxicology Experts To Advise President on Bioethics of Nanomedicine

Published on June 26, 2007 at 1:41 PM

One of today’s hottest areas of scientific research is nanomedicine. Scientists currently are working to create novel nanostructures that can serve as new kinds of drugs for treating cancer, Parkinson’s, and cardiovascular disease. They also are seeking ways to engineer nanomaterials for use as artificial tissues that could replace diseased kidneys and livers, and even repair nerve damage.

In addition, although the research is still exploratory, scientists are beginning to build nanostructures that mimic complex biomolecules. Some of these engineered structures appear to have regenerative powers that could potentially lead to therapies for conditions such as Alzheimer’s, nerve injury and brain damage from stroke.

Dr. Andrew Maynard, chief science advisor for the Wilson Center’s Project on Emerging Nanotechnologies, and Dr. Mauro Ferrari, chairman, Department of Biomedical Engineering, University of Texas Health Science Center at Houston, have been invited to discuss nanotechnology and nanomedicine before a meeting of the President’s Council on Bioethics. At a special session on nanotechnology to be held on Friday, June 29th, beginning at 8:30 a.m., they will present the exciting possibilities that these technologies present, as well as potenial risks and ethical implications.

For a full meeting agenda, see: http://www.bioethics.gov/transcripts/june07/juneagenda.html

Meeting press contact is: Diane M. Gianelli, Director of Communications, The President’s Council on Bioethics, (202) 296-4669.

To learn more about nanotechnology, particularly its medical applications, log onto the report NanoFrontiers: Visions for the Future of Nanotechnology at www.nanotechproject.org/119

  • Who:    Dr. Andrew D. Maynard, Chief Science Advisor, Project on Emerging Nanotechnologies & Dr. Mauro Ferrari, Chairman, Department of Biomedical Engineering, University of Texas Health Science Center at Houston
  • What:    President’s Council on Bioethics meeting, session on nanotechnology           
  • When:        Friday, June 29, 2007, 8:30 a.m. - 11:45 a.m
  • Where:    Hay-Adams Hotel, 16th & H Streets, NW, Washington, DC 

The Project on Emerging Nanotechnologies was launched in 2005 by the Woodrow Wilson Center and The Pew Charitable Trusts. It is dedicated to helping businesses, governments, and the public anticipate and manage the possible health and environmental implications of nanotechnology.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit